|
Variables
|
Phylloquinone
|
%ucOC
|
PIVKA-II
|
|---|
| |
r
|
p
|
r
|
p
|
r
|
p
|
|
Demographic variables
| | | | | | |
|
Age, years
|
0.108
|
0.49
|
0.063
|
0.69
|
0.37
|
0.015
|
|
Dialysis vintage, months
|
-0.25
|
0.11
|
0.06
|
0.72
|
-0.04
|
0.82
|
| |
Mean ± SD
|
p
|
Mean ± SD
|
p
|
Mean ± SD
|
p
|
|
Sex
| | | | | | |
|
Male
|
1.27 ± 1.23
|
0.91
|
25.4 ± 16.6
|
0.87
|
3.93 ± 2.47
|
0.98
|
|
Female
|
1.21 ± 1.08
|
22.9 ± 13.4
|
4.09 ± 2.66
|
|
Etiology of ESKD
| | | | | | |
|
Diabetes mellitus
|
1.13 ± 0.99
|
0.98
|
23.9 ± 16.8
|
0.93
|
4.11 ± 1.98
|
0.22
|
|
Renovascular disease
|
1.33 ± 1.34
|
25.5 ± 15.0
|
4.48 ± 3.10
|
|
Other
|
1.25 ± 1.19
|
24.3 ± 15.7
|
3.55 ± 2.35
|
|
Cardiovascular disease
|
Yes
|
1.15 + 1.01
|
0.72
|
19.8 ± 13.7
|
0.12
|
5.16 ± 3.26
|
0.009
|
| |
No
|
1.29 ± 1.25
|
26.9 ± 15.9
|
3.44 ± 1.90
|
|
Peripheral vascular disease
|
Yes
|
1.25 ± 1.36
|
0.52
|
23.2 ± 15.0
|
0.53
|
4.61 ± 2.73
|
0.08
|
| |
No
|
1.24 ± 1.06
|
25.4 ± 15.9
|
3.59 ± 2.33
|
|
Cerebrovascular disease
|
Yes
|
1.15 ± 1.15
|
0.84
|
16.0 ± 14.2
|
0.048
|
5.20 ± 3.93
|
0.58
|
| |
No
|
1.26 ± 1.19
|
26.0 ± 15.3
|
3.79 ± 2.22
|
|
History of fracture
|
Yes
|
0.94 ± 0.85
|
0.20
|
19.6 ± 14.8
|
0.035
|
4.08 ± 2.87
|
0.55
|
| |
No
|
1.44 ± 1.31
|
27.9 ± 15.1
|
3.93 ± 2.31
|
|
Smoking status
|
Current
|
0.55 ± 0.45
|
0.043
|
29.6 ± 20.0
|
0.55
|
3.74 ± 1.08
|
0.09
|
| |
Former
|
1.65 ± 1.47
|
24.2 ± 13.4
|
4.44 ± 2.51
|
| |
Never
|
1.12 ± 0.84
|
22.4 ± 15.4
|
3.59 ± 2.98
|
| |
r
|
p
|
r
|
p
|
r
|
p
|
|
Laboratory variables
| | | | | | |
|
Phosphate, mmol/L
|
-0.05
|
0.77
|
0.30
|
0.06
|
0.15
|
0.35
|
|
Calcium, ionized, mmol/L
|
0.15
|
0.33
|
0.22
|
0.18
|
0.08
|
0.63
|
|
Calcium-phosphate product, mmol2/L2
|
0.06
|
0.69
|
0.40
|
0.009
|
0.20
|
0.19
|
|
PTH, pmol/L
|
0.05
|
0.76
|
-0.26
|
0.10
|
-0.05
|
0.74
|
|
Albumin, g/L
|
-0.003
|
0.99
|
-0.07
|
0.66
|
-0.07
|
0.65
|
|
Total cholesterol, mmol/L
|
0.43
|
0.004
|
0.14
|
0.39
|
0.14
|
0.37
|
|
LDL cholesterol, mmol/L
|
0.17
|
0.30
|
0.22
|
0.18
|
0.21
|
0.19
|
|
HDL cholesterol, mmol/L
|
-0.04
|
0.82
|
0.26
|
0.10
|
-0.31
|
0.046
|
|
Triglycerides, mmol/L
|
0.45
|
0.002
|
-0.13
|
0.42
|
0.19
|
0.22
|
|
Kt/V
|
0.11
|
0.48
|
0.15
|
0.35
|
-0.33
|
0.027
|
|
URR
|
0.04
|
0.80
|
0.05
|
0.73
|
-0.06
|
0.68
|
- ESKD, End-stage kidney disease; PTH, Parathyroid hormone; LDL, Low-density lipoprotein; HDL, High-density lipoprotein; Kt/V, measure of dialysis adequacy; URR, urea reduction ratio.
